Navigation Links
Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
Date:9/4/2008

BIRMINGHAM, Ala., Sept. 4 /PRNewswire/ -- Southern Research Institute today announced that the National Institutes of Health (NIH) has selected the organization to participate in the newly-funded Molecular Libraries Probe Production Center Network (MLPCN). The MLPCN -- a collaborative research network -- is part of the Molecular Libraries Program which is designed to benefit human health, broaden scientific knowledge of the human genome and validate future targets for drug discovery.

Southern Research will receive $14.7 million in NIH grant support during the six-year period to conduct work at Southern Research's Specialized Biocontainment Screening Center (SRSBSC). The SRSBSC will provide the results from five assays per year that identify protein function and signaling pathways in pathogen-infected cells which will lead to hit identification and characterization. The SRSBSC will provide a platform for assays requiring Biosafety Levels 2 and 3 for high throughput screening and secondary assays.

"While the focus of the SRSBSC team is on virology, our infrastructure would support the screening of other pathogens requiring containment," said Colleen Jonsson, principal investigator for the SRSBSC.

"Winning this award is a testament to Southern Research's strong capabilities in infectious disease research, and reinforces Southern's commitment to the MLPCN and the initiatives within the National Institutes of Health's Roadmap for Medical Research," said Wilson Blaine Knight, Ph.D, vice president, Drug Discovery, Southern Research Institute. "These initiatives place data in the public domain which will enhance the success in the discovery and development of significant medicines to help improve health and therefore the quality of our lives."

SRSBSC efforts should accelerate the discovery of targets for therapeutic intervention, and reveal biomarkers of infection that could be used for early diagnosis of viral infections. There are more t
'/>"/>

SOURCE Southern Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
2. New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis
3. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
4. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
5. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
6. Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists
7. Dallas Researchers Find Compression Stockings Improperly Used
8. MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
9. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
10. New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating, Often Fatal Disease
11. Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , WALTHAM, Mass., Nov. 25 Acc...bal authority on medical technology market intelli...fixation devices will continue to see rapid growth...mic slowdown. MRG,s US Markets for Trauma Devices... highly dynamic over the next five years, with com...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlin...t is available in its catalogue: ,, Intranasal... http://www.reportlinker.com/p0164267/Intranasal-D..., The US intranasal drug delivery market is witn...om the delivery of conventional local therapeutic ...
(Date:11/24/2009)... , BETHESDA, Md., Nov. 24 /PRNewswire-Asia/...q: CHDX ), a leading independent American provide...he People,s Republic of China, today,announced tha...ffray,"Unplugged" Health Care Conference, to be he...tel. , Management is currently scheduled ...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5Chindex International to Present at Piper Jaffray Health Care Conference 2Indiana Drug Card to Provide Free Drug Cards to Residents 53014 1Indiana Drug Card to Provide Free Drug Cards to Residents 53014 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 1Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 2Human Genome Sciences Announces Pricing of Public Offering of Common Stock 13237 3Tanning Beds Get Highest Carcinogen Rating 53009 1Tanning Beds Get Highest Carcinogen Rating 53009 2Tanning Beds Get Highest Carcinogen Rating 53009 3
...ath by 13% (P=0.08), despite inclusion of patients... , - In a separate censored analysis excluding...tion in risk of death was 19% , , - Long-term...einforces starting with Femara as the optimal trea...VER, N.J., Dec. 11 New long-term data from a majo...
...Jersey and PHILADELPHIA, December 11, Rosetta Geno...icroRNA-based molecular diagnostics, announced tod...stic test, miRview(TM) squamous.,The test is now c...A-certified lab in Philadelphia. , To order ...r visit the,company,s website http://www.rosettag...
Other Medicine Technology:Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 2Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 3Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 4Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 5Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 6Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 7Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery 8Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 2Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA-Based Diagnostic Test; Will Host Teleconference to Discuss Launch of Future Tests 5
(Date:11/27/2009)... , SEATTLE, Nov. 27 /PRNewswire/ -...ceived record-high Thanksgiving traffic numbers, w...Thanksgiving, providing a clear picture of what wa...The average Thanksgiving meal in 2009 weighed in a... from last year,s feast. According to the Allrecip...
(Date:11/27/2009)... Three new interactive anatomy edu...& Wilkins expand health sciences learning oppo... Durham, NC (Vocus) November 27, 2009 ...Wilkins (LWW), a division of Wolters Kluwer Health...atomy education apps on the App Store. Clemente&rs...
(Date:11/26/2009)...per sequestering drug tetrathiomolybdate (TM) has ...ment of Wilson disease, a disease caused by an ove...hat much is known. Very little, however, is known ..., A new study led by Northwestern University rese...hree-dimensional structure of TM bound to copper-l...
(Date:11/26/2009)... Dr. David Kim of the Live Life Ag...ry in Dallas , is one of a growing number of physi...networking sites to connect with individuals who a... fight morbid obesity. Dr. Kim is utilizing Facebo...n about his practice with the community. , ...
(Date:11/25/2009)..., EDINA, Minn., Nov. 25 /PRNewswire-USNewswire/ -...k of their dentist. But a chiropractor can also g...e Temporal-Mandibular Joint, which is where your j...emporal bone). ,, The most common symptoms ass..., clicking or popping of the jaw. But many other ...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...ntly end use of Trasylol, experts say , , ...an study confirms that people given Trasylol, a dr...ncreases their risk of death by 53 percent. , Tras... the medication. , "In the trial, we asked whether...
...a families with high rates of late-onset Alzheimer...ease, researchers say. , Genetic variations calle...mmon in DNA, but this pattern of SNPs shows up in ... Studies and the Charlie Norwood Veterans Affairs ...
...HINGTON, May 14 The American Red Cross,will honor...ward at the,organization,s Heritage of Service Din...s a celebration to recognize the outstanding dedic...undo is,being recognized for its contribution in c...
...nd Payment, CINCINNATI, May 14 LCA-Vision Inc. (...correction services under the,LasikPlus(R) brand, ...onday, May 12, 2008. At the meeting, stockholders ..., Co-Founder and President of Bahl & Gaynor Invest...
...ived the annual Joseph F. Boyle Award for Distingu...Physicians (ACP) last night. The award is given to... official capacity who has provided outstanding pu... board of governors, cited her role in working wit...
...CYBX) today announced that the company will report...al year ended April 25, 2008 on Wednesday, June,11...conference call to,discuss those results at 9:00 A...e dial 877-313-8035,(if dialing from within the U....
Other Medicine News:Health News:Danger From Heart Surgery Drug Confirmed 2Health News:Danger From Heart Surgery Drug Confirmed 3Health News:Danger From Heart Surgery Drug Confirmed 4Health News:Families shed light on likely causative gene for Alzheimer's 2Health News:American Red Cross Honors Telemundo at Heritage of Service Dinner 2Health News:American Red Cross Honors Telemundo at Heritage of Service Dinner 3Health News:LCA-Vision Conducts 2008 Annual Stockholder Meeting 2Health News:LCA-Vision Conducts 2008 Annual Stockholder Meeting 3Health News:Ohio congresswoman cited by American College of Physicians 2Health News:Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results 2
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: